Lisinopril

Lisinopril
Details:
CAS No. 83915-83-9
Molecular Formula: C21H31N3O5
Molecular Weight: 405.49 g/mol
Send Inquiry
Chat Now
Download
Description
Technical Parameters

Lisinopril is an angiotensin-converting enzyme inhibitor used in formulations targeting essential hypertension, renovascular hypertension, and symptomatic heart failure. By suppressing the conversion of angiotensin I to angiotensin II, it reduces plasma angiotensin II levels, decreases vasopressor activity, and lowers aldosterone secretion. Production adheres to current Good Manufacturing Practice guidelines, ensuring precise assay compliance and consistent solid-state properties suitable for direct compression and wet granulation tableting processes.

 

Product Information

 

Parameter

Specification Details

International Nonproprietary Name

Lisinopril

Chemical Name

(S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate

CAS Registry Number

83915-83-9

Molecular Formula

C21H31N3O5

Molecular Weight

405.49 g/mol

Structural Class

Dicarboxylate-containing ACE inhibitor

Pharmacopeial Compliance

USP / EP / BP

Storage Conditions

Store in tight containers at 15°C to 30°C, protected from moisture and light

Shelf Life

36 months from the date of manufacture

 

Quality and Specification

 

Test Parameter

Acceptance Criteria

Description

White or almost white, crystalline powder

Solubility

Sparingly soluble in water, freely soluble in methanol, practically insoluble in ethanol

Identification

Infrared absorption spectrum matches reference standard; retention time conforms to reference solution

Specific Optical Rotation

-47.0° to -52.0° calculated on the anhydrous substance

Water Content

8.5% to 10.5% determined by Karl Fischer titration

Residue on Ignition

Maximum 0.1%

Heavy Metals

Maximum 10 ppm

Related Substances

Individual impurity $\le$ 0.10%; Total impurities $\le$ 0.5%

Assay

98.5% to 101.5% calculated on the dried basis

 

Manufacturing and Supply

 

Synthesis Route: Liquid-phase and stereoselective catalytic hydrogenation processes ensuring high chiral purity.

 

Purification Process: Multi-stage crystallization, controlled temperature filtration, and vacuum drying to achieve targeted particle size distribution profiles.

 

Cleanroom Environment: Isolation, milling, and packaging executed inside ISO Class 8 cleanrooms equipped with continuous differential pressure and high-efficiency particulate air filtration.

 

Equipment Trains: Reaction trains utilizing glass-lined and stainless steel reactors, automated centrifuge systems, and agitated nutsche filter-dryers.

 

In-Process Controls: Automated monitoring of pH, temperature, agitation speed, and residual solvent concentrations using gas chromatography and high-performance liquid chromatography.

 

Supply Capacity: Scalable production capacity ranging from pilot validation batches to commercial multi-metric ton supplies per annum.

 

Documentation

01/

Regulatory Dossiers: Drug Master File available for global regulatory filing and reference.

02/

Analytical Documentation: Certificate of Analysis issued for every production batch detailing exact assay, impurity levels, and physical parameters.

03/

Compliance Certificates: Written Confirmation for active substances imported into the European Union, Good Manufacturing Practice certificates, and Certificate of Suitability status upon request.

04/

Safety Data: Detailed Safety Data Sheet covering handling, storage, occupational exposure limits, and environmental precautions.

05/

Traceability Records: Complete batch production records, raw material genealogy reports, and analytical raw data available for quality audits.

Packaging

 

Primary Packaging

Double-layer low-density polyethylene bags heat-sealed under positive pressure.

Secondary Packaging

Rigid, moisture-tight fiber drums or high-density polyethylene drums containing tamper-evident seals.

Desiccant Integration

Silica gel packets positioned between primary and secondary layers to prevent moisture degradation during transit.

Standard Dimensions

Net weight 25 kg per drum with customized configurations available upon validated request.

Labeling Compliance

Outer drums labeled with product name, CAS number, batch number, manufacturing date, retest date, net weight, gross weight, storage requirements, and hazard warnings.

 

Pharmaceutical Application

 

Essential Hypertension: Formulated into oral tablets for monotherapy or combination therapy to lower systemic arterial blood pressure by decreasing vascular resistance.

 

Congestive Heart Failure: Utilized as adjunctive pharmacological therapy to reduce cardiac preload and afterload, improving myocardial survival and functional capacity.

 

Acute Myocardial Infarction: Administered in hemodynamically stable patients within 24 hours of infarction to prevent ventricular remodeling and preserve left ventricular systolic function.

 

Diabetic Nephropathy: Applied in patients with type 2 diabetes mellitus to lower intraglomerular pressure, mitigate microalbuminuria, and slow the progression of renal disease.

 

FAQ

 

Q: What is the standard packaging size for commercial orders of Lisinopril API?

A: The standard export packaging is 25 kg net weight packed in double low-density polyethylene bags sealed inside a high-density polyethylene or fiber drum.

Q: Is a Drug Master File available for regulatory submission?

A: Yes, a comprehensive Drug Master File is maintained and available to support customer regulatory filings across global jurisdictions.

Q: What pharmacopeial standards does this Lisinopril API comply with?

A: The material is manufactured and tested in accordance with United States Pharmacopeia and European Pharmacopoeia monographs.

Q: What are the recommended storage conditions to ensure chemical stability?

A: Store in tightly closed containers at controlled room temperature between 15°C and 30°C, protected from direct exposure to moisture, light, and heat.

Q: What analytical methods are used to control impurity profiles?

A: Related substances and degradation products are quantified using validated high-performance liquid chromatography methods compliant with international guidelines.

 

Hot Tags: lisinopril, China lisinopril manufacturers, suppliers, factory

Send Inquiry